Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Early post-discharge ambulatory cardiac rehabilitation after acute heart failure: a randomized prospective study
Session:
Sessão de Comunicações Orais 08 – Reabilitação Cardíaca como terapia: recuperação funcional na doença cardiovascular avançada
Speaker:
Francisco Rodrigues Dos Santos
Congress:
CPC 2026
Topic:
J. Preventive Cardiology
Theme:
29. Rehabilitation and Sports Cardiology
Subtheme:
29.2 Cardiovascular Rehabilitation
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Francisco Rodrigues dos Santos; Oliver Correia Kungel; Gonçalo Ferreira; João Gouveia Fiúza; Mariana Duarte Almeida; Luís Afonso Santos; António Costa; Inês Fiúza Pires
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="font-family:"Calibri",sans-serif">Background:</span></strong> <span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">Cardiac rehabilitation (CR) is a cornerstone therapy for patients hospitalized with acute heart failure (AHF), with early inpatient rehabilitation (Phase I) contributing to functional recovery and Phase II programs playing a key role in longitudinal follow-up. However, the transition period between hospital discharge and initiation of Phase II—typically weeks—remains a vulnerable window associated with high rates of early readmission. This study aimed to evaluate the impact of an early, structured, post-discharge ambulatory CR strategy implemented in a center without a dedicated rehabilitation program.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">Methods:</span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"> We conducted a prospective, 1:1 randomized study with an estimated 1-year recruitment period and 2-year follow-up. Consecutive patients aged 18–80 years admitted with AHF and left ventricular ejection fraction (LVEF) <50%, autonomous in daily activities and without contraindications to light-to-moderate exercise were randomized according to date of admission. The intervention group received detailed baseline assessment, individualized exercise prescription, and in-person reassessment every two weeks with iterative adjustment of the exercise plan. The control group received standard of care with routine outpatient follow-up and guideline-directed medical therapy titration. Kansas City Cardiomyopathy Questionnaire (KCCQ) scores and 6-minute walk test (6MWT) performance were obtained at discharge and at 3 months. Emergency visits, hospitalizations, and mortality were recorded. This abstract reports the 3-month </span></span><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">interim analysis. </span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">Results:</span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"> 38 patients were included (19 control vs 19 intervention), age (66.6 vs 64.2 years), length of stay (8.6 vs 8.5 days), discharge LVEF (34.1% vs 33.8%), TAPSE (19.2 vs 18.5 mm), LV end-diastolic volume (96.9 vs 95.2 mL), BMI (27.9 vs 28.7 kg/m²), NT-proBNP (5882 vs 4863 pg/mL), initial 6MWT distance (360.9 vs 377.4 m), and KCCQ score (61.1 vs 54.4), all p>0.05. At 3 months, the intervention group achieved greater improvements in both functional capacity and quality of life: 6MWT change (+47.5 ± 31 m vs +25 ± 36 m; p=0.029) and KCCQ change (+22.2 ± 21.9 vs. +7.9 ± 9.2; p=0.017). Kaplan–Meier analyses showed lower cumulative incidence of HF-related and all-cause hospitalizations, as well as fewer emergency department visits, in the intervention group, although without statistical significance at 3 months (p=0.10) (figure 1). Mortality was 0 in the intervention group and 2 in the control group. </span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">Conclusions:</span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"> Early post-discharge ambulatory CR appears safe and demonstrates clinically meaningful improvements in functional capacity and quality of life, with encouraging early signals toward reduction in hospitalizations. Long-term results from the planned 2-year follow-up may clarify its impact on major clinical endpoints and support its implementation in centers without established center-based CR programs.</span></span></span></span></p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site